ID: ALA2074897

Max Phase: Preclinical

Molecular Formula: C11H12NO+

Molecular Weight: 174.22

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  OCC[n+]1cccc2ccccc21

Standard InChI:  InChI=1S/C11H12NO/c13-9-8-12-7-3-5-10-4-1-2-6-11(10)12/h1-7,13H,8-9H2/q+1

Standard InChI Key:  RBLABOQYMJOPQE-UHFFFAOYSA-N

Associated Targets(Human)

Solute carrier family 22 member 1 646 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 174.22Molecular Weight (Monoisotopic): 174.0913AlogP: 1.12#Rotatable Bonds: 2
Polar Surface Area: 24.11Molecular Species: NEUTRALHBA: 1HBD: 1
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: -2.86CX LogD: -2.86
Aromatic Rings: 2Heavy Atoms: 13QED Weighted: 0.68Np Likeness Score: 0.17

References

1. Bednarczyk D, Ekins S, Wikel JH, Wright SH..  (2003)  Influence of molecular structure on substrate binding to the human organic cation transporter, hOCT1.,  63  (1): [PMID:12606755] [10.1124/mol.63.3.489]